Penttinen J - Search Results

1

Serum concentrations of CA 125 and aminoterminal propeptide of type III procollagen (PIIINP) in patients with endometrial carcinoma.

Tomás C, Penttinen J, Risteli J, Risteli L, Vuori J, Kauppila A. Tomás C, et al. Among authors: penttinen j. Cancer. 1990 Dec 1;66(11):2399-406. doi: 10.1002/1097-0142(19901201)66:11<2399::aid-cncr2820661126>3.0.co;2-e. Cancer. 1990. PMID: 2245396

2

Simultaneous evaluation of epithelial cell function by CA 125 and stromal cell activity by aminoterminal propeptide of type III procollagen (PIIINP) in ovarian carcinoma.

Tomás C, Penttinen J, Risteli J, Risteli L, Kauppila A. Tomás C, et al. Among authors: penttinen j. Ann Med. 1990 Apr;22(2):115-21. doi: 10.3109/07853899009147253. Ann Med. 1990. PMID: 2361007 Free article.

3

Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapy.

Suvanto-Luukkonen E, Risteli L, Sundström H, Penttinen J, Kauppila A, Risteli J. Suvanto-Luukkonen E, et al. Among authors: penttinen j. Clin Chim Acta. 1997 Oct 31;266(2):105-16. doi: 10.1016/s0009-8981(97)00140-x. Clin Chim Acta. 1997. PMID: 9437539

4

Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.

Suvanto-Luukkonen E, Malinen H, Sundström H, Penttinen J, Kauppila A. Suvanto-Luukkonen E, et al. Among authors: penttinen j. Acta Obstet Gynecol Scand. 1998 Aug;77(7):758-63. Acta Obstet Gynecol Scand. 1998. PMID: 9740525

5

Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy.

Martikainen H, Penttinen J, Huhtaniemi I, Kauppila A. Martikainen H, et al. Among authors: penttinen j. Gynecol Oncol. 1989 Dec;35(3):406-8. doi: 10.1016/0090-8258(89)90089-9. Gynecol Oncol. 1989. PMID: 2532171

6

Effect of suprapubic operation on urethral closure. Evaluation by single cough urethrocystometry.

Penttinen J, Käär K, Kauppila A. Penttinen J, et al. Br J Urol. 1989 Apr;63(4):389-91. doi: 10.1111/j.1464-410x.1989.tb05224.x. Br J Urol. 1989. PMID: 2713620

7

Colposuspension and transvaginal bladder neck suspension in the treatment of stress incontinence.

Penttinen J, Kaar K, Kauppila A. Penttinen J, et al. Gynecol Obstet Invest. 1989;28(2):101-5. doi: 10.1159/000293525. Gynecol Obstet Invest. 1989. PMID: 2792913

8

Six-microtransducer catheter connected to computer in evaluation of urethral closure function of women.

Kauppila A, Penttinen J, Häggman VM. Kauppila A, et al. Among authors: penttinen j. Urology. 1989 Feb;33(2):159-64. doi: 10.1016/0090-4295(89)90019-8. Urology. 1989. PMID: 2916292

9

Insulin-like growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy.

Suvanto-Luukkonen E, Sundström H, Penttinen J, Kauppila A, Rutanen EM. Suvanto-Luukkonen E, et al. Among authors: penttinen j. Maturitas. 1995 Nov;22(3):255-62. doi: 10.1016/0378-5122(95)00935-e. Maturitas. 1995. PMID: 8746884

10

Successful colposuspension in stress urinary incontinence reduces bladder neck mobility and increases pressure transmission to the urethra.

Penttinen J, Lindholm EL, Käär K, Kauppila A. Penttinen J, et al. Arch Gynecol Obstet. 1989;244(4):233-8. doi: 10.1007/BF01560087. Arch Gynecol Obstet. 1989. PMID: 2782951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters